Jos W. M. van der Meer, MD, PhD, FRCP | Psychiatrist.com

Original Research

The Effect of Ondansetron, a 5-HT3 Receptor Antagonist, in Chronic Fatigue Syndrome: A Randomized Controlled Trial

January 26, 2010

Gerard K. H. The, Gijs Bleijenberg, Jan K. Buitelaar, et al